Evolv posted a wider-than-expected adjusted loss in Q4, but sales beat expectations.
The company issued strong guidance for 2026, and it also announced new contract extensions with major pro-sports teams.
Despite bearish momentum shaping the broader market in March, Evolv Technologies (NASDAQ: EVLV) stock managed to post big gains. The company's share price climbed 14.2% in the month. Over the same period, the S&P 500 and the Nasdaq Composite declined 5.1% and 4.8%, respectively.
Evolv's market-beating performance stemmed from a solid quarterly report and strong forward guidance. Even with the gains, the stock is still down roughly 16% across 2026's trading.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
Evolv report its fourth-quarter results on March 10, reporting earnings that missed Wall Street's guidance but sales that exceeded expectations. The company recorded a non-GAAP (adjusted) loss of $0.03 per share on sales of $38.5 million. For comparison, the average Wall Street analyst estimate had targeted an adjusted per-share loss of $0.02 on sales of $36.44 million.
Sales increased 32% year over year in Q4, and the business generated GAAP net income of $10.9 million in the period -- representing a net-income margin of 28%. The profit marked a substantial improvement over the $15.7 million net loss recorded in last year's quarter. The company also closed out last year with annual recurring revenue (ARR) of $120.5 million -- good for year-over-year growth of 21%.
Along with its Q4 report, Evolv raised its 2026 revenue target to between $172 million and $178 million. Previously, the company had targeted sales between $160 million and $165 million for the year. Meanwhile, ARR for 2026 is projected to grow between 20% and 25%. Guidance for strong growth this year helped power substantial gains for the stock despite a bearish backdrop for the broader market.
Evolv also followed its Q4 report with news of two significant contract extensions. The security company announced that it had extended its contract with the NFL's Tennessee Titans on March 12 and then announced on March 18 that it extended its service contract with the MLB's Houston Astros. The deal with the Astros marks the first adoption of Evolv's eXpedite artificial intelligence (AI) systems for weapons detection in a professional baseball stadium.
Thanks in part to recovery momentum for the broader market, Evolv stock's hot streak has extended into April. The company's share price is up roughly 6.2% in the month so far. Meanwhile, the S&P 500 is up 3.8%, and the Nasdaq Composite is up 5.2%.
The broader market's gains have been driven by hopes that the war with Iran could begin winding down in the not-too-distant future. On the other hand, recent comments from President Donald Trump suggesting that the U.S. could soon strike major Iranian infrastructure targets could spur another round of bearish volatility for stocks.
Before you buy stock in Evolv Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Evolv Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $532,066!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,087,496!*
Now, it’s worth noting Stock Advisor’s total average return is 926% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of April 6, 2026.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.